Mitchell Kennedy

Life sciences industry leader Mitchell (Mitch) Kennedy joined The Jackson Laboratory as executive vice president of JAX and president of JAX® Mice, Clinical and Research Services (JMCRS) in April of 2023. In this role, Kennedy determines and leads the functions of product development, business development, business unit management, marketing, field representation, and customer support for JMCRS and leads all JMCRS operational groups.

Kennedy has more than 25 years in senior leadership roles in the life sciences industry, most recently serving at Thermo Fisher Scientific for over 16 years, where he was responsible for revenue as large as $2B and 6000+ employees. Before his departure in 2022, he served as division president for single use technologies, accounting for $1.7 billion in revenue and covering products including hardware and controllers, hardware consumables, and 3D/2D bioprocess containers used in pharmaceutical production. In this role he led continuous improvement, cost management, pricing strategy, and operations scale-up to meet growing demand. Prior to that, he held roles as division president for chromatography and mass spectrometry (CMD), served as general manager and vice president of the life sciences business unit within CMD, and general manager and vice president of the molecular biology business unit.

Before joining Thermo Fisher, Kennedy held various roles in general management for Affymetrix, playing a key role in the strategy and execution of the company’s business plan. Prior to joining Affymetrix, Kennedy worked with a number of life science companies including Applied Biosystems, Perkin-Elmer, Amersham, and Bio-Rad in a range of product management, commercial, marketing, and technical support roles. He completed field lab study at the University of Oregon’s Oregon Institute of Marine Biology, and graduated from the University of California, Berkeley with a B.A. in marine biology and zoology.